Medical technology

AdjuCor Raises € 29 Million in Series B Funding Round for its Revolutionary Heart Assist Technology that Completely Avoids Blood Contact

Retrieved on: 
Wednesday, June 9, 2021

MUNICH, Germany, June 9, 2021 /PRNewswire-PRWeb/ --AdjuCor is developing an implantable heart assist device that, contrary to all existing heart assist devices, has the capability to assist the heart while completely avoiding the complication-laden aspect of blood contact.

Key Points: 
  • MUNICH, Germany, June 9, 2021 /PRNewswire-PRWeb/ --AdjuCor is developing an implantable heart assist device that, contrary to all existing heart assist devices, has the capability to assist the heart while completely avoiding the complication-laden aspect of blood contact.
  • Securing the 29 million of this round and getting MitrAssist Holdings Limited on board are exactly what AdjuCor has been looking for to reach its goals".
  • It is implanted by a heart team (cardiologist and surgeon) within a few minutes on the beating heart without sutures.
  • It completely avoids blood contact and thereby any blood-related complications including strokes and bleeding an invaluable advantage that cannot be over-stated.

National Plaintiffs Firm Investigating Injuries and Deaths Linked To Recalled Heart Pump

Retrieved on: 
Tuesday, June 8, 2021

BALTIMORE and COLUMBIA, S.C., June 8, 2021 /PRNewswire/ --Janet, Janet & Suggs, LLC, a national plaintiffs' law firm, is investigating patient injuries and deaths that may be due to a defective, and now, recalled heart pump system.

Key Points: 
  • BALTIMORE and COLUMBIA, S.C., June 8, 2021 /PRNewswire/ --Janet, Janet & Suggs, LLC, a national plaintiffs' law firm, is investigating patient injuries and deaths that may be due to a defective, and now, recalled heart pump system.
  • On June 3, 2021, Medtronic announced that it was stopping the sale of its HeartWare Ventricular Assist Device (HVAD) System due to safety concerns.
  • Janet, Janet & Suggs, LLC is currently investigating legal action on behalf of clients with damages arising from pump failures and neurologic injuries associated with the Medtronic HVAD system.
  • Janet, Janet and Suggs, LLC (JJS) is a national firm with offices in ten states and Washington D.C.

Five Day Online Medical Device Summer School: From Concept to CE Marking Training Course, July 5th-9th, 2021 - ResearchAndMarkets.com

Retrieved on: 
Friday, June 4, 2021

The "The Medical Device Summer School - From Concept to CE Marking Training Course" conference has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "The Medical Device Summer School - From Concept to CE Marking Training Course" conference has been added to ResearchAndMarkets.com's offering.
  • Bringing a medical device to the marketplace is a complex and lengthy procedure which requires experience, knowledge and specialist skills.
  • This event has been designed primarily for those who wish to understand the processes involved in bringing a medical device to market.
  • General medical devices as well as active implantable, in-vitro diagnostic and drug device products will be covered in the programme.

Vicarious Surgical Appoints Michael Pratt as Vice President of Commercial Strategy

Retrieved on: 
Thursday, June 3, 2021

WALTHAM, Mass., June 3, 2021 /PRNewswire/ -- Vicarious Surgical Inc. ("Vicarious" or "Vicarious Surgical" or the "Company"), a next-generation robotics technology company seeking to improve both cost and efficiency of surgical procedures as well as patient outcomes, today announced the appointment of Michael Pratt as Vice President of Commercial Strategy.

Key Points: 
  • WALTHAM, Mass., June 3, 2021 /PRNewswire/ -- Vicarious Surgical Inc. ("Vicarious" or "Vicarious Surgical" or the "Company"), a next-generation robotics technology company seeking to improve both cost and efficiency of surgical procedures as well as patient outcomes, today announced the appointment of Michael Pratt as Vice President of Commercial Strategy.
  • Prior to joining Vicarious Surgical, Mr. Pratt served as Global Vice President at Ekso Bionics where he relaunched Ekso's industrial exoskeleton business unit, leading a capital raise as well as executing a managed buyout and scaling within a projected $3 billion market.
  • "Michael's deep commercial expertise within the surgical robotics field will be invaluable as we continue to execute on our strategy to bring our next-generation surgical robotic technology to the market," said Adam Sachs, Co-Founder and Chief Executive Officer of Vicarious Surgical.
  • "I'm thrilled to join the high caliber team at Vicarious Surgical during this period of rapid growth," said Mr. Pratt.

Dexcom Looks to the Future of Continuous Glucose Monitoring

Retrieved on: 
Thursday, June 3, 2021

DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the publication and presentation of two new studies during the 14th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD).

Key Points: 
  • DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the publication and presentation of two new studies during the 14th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD).
  • With the publication of the MOBILE data, Dexcom has now demonstrated significant outcomes driven by its CGM technology in randomized controlled trials across the full spectrum of insulin use in people with diabetes.
  • The clinical benefits of Dexcom CGM were seen across all patient demographics regardless of age, education, numeracy or socioeconomic status, said David Price, MD, vice president of medical affairs at Dexcom.
  • DexCom, Inc., headquartered in San Diego, CA, is dedicated to helping people better manage their diabetes by developing and marketing continuous glucose monitoring (CGM) products and tools for adult and pediatric patients.

Global Mobility Aids and Transportation Equipment Market Report 2021: Long-term Forecast to 2025 & 2030 - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 3, 2021

The "Mobility Aids and Transportation Equipment Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Mobility Aids and Transportation Equipment Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering.
  • Major players in the mobility aids and transportation equipment market are Medline Industries, Hoveround Corporation, Sunrise Medical LLC, OttoBock Healthcare GmbH and Stryker Corporation.
  • Global Mobility Aids And Transportation Equipment Forecast Market, 2020-2025F, 2030F, $ Billion
    6.1.
  • Global Mobility Aids And Transportation Equipment Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

KoKo and EirMed Announce Joint Manufacturing Partnership

Retrieved on: 
Wednesday, June 2, 2021

LONGMONT, Colo., June 2, 2021 /PRNewswire/ --KoKo, a developer of respiratory information systems software and medical devices, and EirMed today announced a joint manufacturing partnership.

Key Points: 
  • LONGMONT, Colo., June 2, 2021 /PRNewswire/ --KoKo, a developer of respiratory information systems software and medical devices, and EirMed today announced a joint manufacturing partnership.
  • The partnership for KoKo and EirMed will streamline the manufacturing of respiratory medical devices deployed globally by medical professionals in the delivery of unparalleled patient care.
  • This partnership streamlines the overall process of product development in the respiratory medical device industry," said Rick Curtis, President of EirMed.
  • EirMed is ISO 13485 certified and has over 50,000 square feet of manufacturing and warehouse space, including more than 13,000 square feet of clean room manufacturing.

KoKo and EirMed Announce Joint Manufacturing Partnership

Retrieved on: 
Wednesday, June 2, 2021

LONGMONT, Colo., June 2, 2021 /PRNewswire/ --KoKo, a developer of respiratory information systems software and medical devices, and EirMed today announced a joint manufacturing partnership.

Key Points: 
  • LONGMONT, Colo., June 2, 2021 /PRNewswire/ --KoKo, a developer of respiratory information systems software and medical devices, and EirMed today announced a joint manufacturing partnership.
  • The partnership for KoKo and EirMed will streamline the manufacturing of respiratory medical devices deployed globally by medical professionals in the delivery of unparalleled patient care.
  • The partnership allows quick optimization of engineering, manufacturing, assembly, and packaging through rapid cycles.
  • EirMed is ISO 13485 certified and has over 50,000 square feet of manufacturing and warehouse space, including more than 13,000 square feet of clean room manufacturing.

Femtech Market Size to Reach Revenues of around USD 75.74 Billion by 2026 - Arizton

Retrieved on: 
Wednesday, June 2, 2021

CHICAGO, June 2, 2021 /PRNewswire/ -- In-depth analysis and data-driven insights on the impact of COVID-19 included in this global femtech market report.

Key Points: 
  • CHICAGO, June 2, 2021 /PRNewswire/ -- In-depth analysis and data-driven insights on the impact of COVID-19 included in this global femtech market report.
  • The femtech market is expected to grow at a CAGR of over 13.32% during the period 20202026.
  • Femtech investors, fitness wearable manufacturers, and health advocates should focus on creating solutions for the entire spectrum of women.
  • Endodiag, a French medical technology company that allows early diagnosis of endometriosis, and iSono Health developed a screening device for breast cancer.

Femtech Market Size to Reach Revenues of around USD 75.74 Billion by 2026 - Arizton

Retrieved on: 
Wednesday, June 2, 2021

CHICAGO, June 2, 2021 /PRNewswire/ -- In-depth analysis and data-driven insights on the impact of COVID-19 included in this global femtech market report.

Key Points: 
  • CHICAGO, June 2, 2021 /PRNewswire/ -- In-depth analysis and data-driven insights on the impact of COVID-19 included in this global femtech market report.
  • The femtech market is expected to grow at a CAGR of over 13.32% during the period 20202026.
  • Femtech investors, fitness wearable manufacturers, and health advocates should focus on creating solutions for the entire spectrum of women.
  • Endodiag, a French medical technology company that allows early diagnosis of endometriosis, and iSono Health developed a screening device for breast cancer.